Excellent background article by Stephanie Oestreich, EVP, North American BRIDGEs Partnerships @evotec examining the reasons for creating LAB150, and aspirations for this new successful drug dev platform: https://teapaw.org/t.co/kCgt0rDTwq
LAB150 is happy to announce its 5th intake program - an anti-depression project from Dr. Jose Nobrega @CAMHResearch https://teapaw.org/t.co/w4GoCdEiwu #mentalhealth@Evotec
We are happy to announce our second project to be developed under our partnership with @EvotecAG: a novel therapeutic approach to treat glaucoma. The project comes from the lab of Dr. Jeremy Sivak at @UHN@KrembilRI https://teapaw.org/t.co/yX1MtVhMhS #glaucoma